Keyphrases
COVID-19
100%
Anticoagulants
62%
Hospitalized Patients
62%
Therapeutic Anticoagulation
56%
Critical Illness
50%
Sickle Cell Disease
50%
Retrospective Cohort Analysis
50%
Venous Thromboembolism Prevention
50%
Medication Adherence
50%
Venous Thromboembolism
50%
Mechanical Ventilation
50%
Patients with COVID-19
50%
Practice Patterns
50%
Practice Outcomes
50%
Pulmonary Embolism
37%
Deep Vein Thrombosis
37%
Thrombosis
31%
Venous Thromboembolism Prophylaxis
25%
Bleeding
25%
Major Bleeding
25%
Arterial Thromboembolism
25%
Clinical Outcomes
18%
Refill Prescription
16%
Prescription Records
16%
Medicaid
16%
Health Maintenance Organizations
16%
Prescription Rate
16%
Insurance
16%
Prescription Refill
16%
Pharmacologic
12%
Bleeding Events
12%
Anticoagulation
12%
SARS-CoV-2 Infection
12%
Venous Thromboembolism Management
12%
Thrombosis Risk
12%
Multivariable Logistic Regression
12%
Arterial Bleeding
12%
Risk Factors
12%
US Hospitals
12%
Bleeding Rate
12%
New Therapeutics
12%
Clinically Significant
12%
Logistic Regression Model
12%
Confounding by Indication
12%
Non-majors
12%
Inverse Probability Weighting
12%
Clinical Concerns
12%
Thromboprophylaxis
12%
Retrospective Longitudinal Study
12%
Odds Ratio
12%
Medicine and Dentistry
Anticoagulation
62%
Prevalence
56%
Venous Thromboembolism
50%
Diseases
50%
Coronavirinae
50%
Sickle-Cell Disease
50%
Medication Compliance
50%
Cohort Analysis
50%
Artificial Respiration
50%
COVID-19
50%
Critical Illness
50%
Anticoagulant
50%
Drug Therapy
33%
Thrombosis
24%
Pulmonary Embolism
18%
Deep Vein Thrombosis
18%
Bleeding
18%
Major Bleeding
12%
Arterial Thromboembolism
12%
Antithrombotic
6%
Logistic Regression Analysis
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Infection
6%
Cross Sectional Study
6%
Odds Ratio
6%
Therapeutic Community
5%
Antiplatelet Drug
5%
Hypercoagulability
5%
Body Mass Index
5%
Observational Study
5%
Outpatient
5%
Nursing and Health Professions
Anticoagulation
62%
Prevalence
56%
Anticoagulant Agent
56%
Sickle Cell Anemia
50%
Venous Thromboembolism
50%
Medication Compliance
50%
Cohort Analysis
50%
Artificial Respiration
50%
Disease
50%
Critical Illness
50%
Drug Therapy
33%
Bleeding
31%
Thrombosis
24%
Lung Embolism
18%
Deep Vein Thrombosis
18%
Health Maintenance Organization
16%
Arterial Thromboembolism
12%
Clinical Outcome
11%
Cross-Sectional Study
6%
Logistic Regression Analysis
6%
Odds Ratio
6%
Infection
6%
Severe Acute Respiratory Syndrome
6%
Therapeutic Community
5%
Outpatient
5%
Body Mass
5%
Hypercoagulability
5%
Antithrombocytic Agent
5%
World Health Organization
5%
